• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[基于天花病毒A30L基因的天花DNA疫苗及其密码子使用修饰变体的保护特性比较]

[Comparison of protective properties of the smallpox DNA-vaccine based on the variola virus A30L gene and its variant with modified codon usage].

作者信息

Maksiutov R A, Shchelkunov S N

出版信息

Mol Gen Mikrobiol Virusol. 2011(2):30-4.

PMID:21786633
Abstract

Efficacy of candidate DNA-vaccines based on the variola virus natural gene A30L and artificial gene A30Lopt with modified codon usage, optimized for expression in mammalian cells, was tested. The groups of mice were intracutaneously immunized three times with three-week intervals with candidate DNA-vaccines: pcDNA_A30L or pcDNA_A30Lopt, and in three weeks after the last immunization all mice in the groups were intraperitoneally infected by the ectromelia virus K1 strain in 10 LD50 dose for the estimation of protection. It was shown that the DNA-vaccines based on natural gene A30L and codon-optimized gene A30Lopt elicited virus, thereby neutralizing the antibody response and protected mice from lethal intraperitoneal challenge with the ectromelia virus with lack of statistically significant difference.

摘要

对基于天花病毒天然基因A30L和密码子使用经过修饰、针对在哺乳动物细胞中表达进行优化的人工基因A30Lopt的候选DNA疫苗的效力进行了测试。将小鼠分组,每隔三周用候选DNA疫苗pcDNA_A30L或pcDNA_A30Lopt进行三次皮内免疫,在最后一次免疫后三周,对各组所有小鼠腹腔注射10 LD50剂量的埃可病毒K1株,以评估保护效果。结果表明,基于天然基因A30L和密码子优化基因A30Lopt的DNA疫苗引发了病毒中和抗体反应,并保护小鼠免受埃可病毒致死性腹腔攻击,且无统计学显著差异。

相似文献

1
[Comparison of protective properties of the smallpox DNA-vaccine based on the variola virus A30L gene and its variant with modified codon usage].[基于天花病毒A30L基因的天花DNA疫苗及其密码子使用修饰变体的保护特性比较]
Mol Gen Mikrobiol Virusol. 2011(2):30-4.
2
An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection.一种减毒的LC16m8天花疫苗:全基因组序列分析及免疫保护诱导
J Virol. 2005 Sep;79(18):11873-91. doi: 10.1128/JVI.79.18.11873-11891.2005.
3
Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens.使用天花大抗原的亚单位天花疫苗的免疫原性和保护效果。
Virology. 2008 Feb 5;371(1):98-107. doi: 10.1016/j.virol.2007.09.029. Epub 2007 Oct 24.
4
Vaccination with a codon-optimized A27L-containing plasmid decreases virus replication and dissemination after vaccinia virus challenge.用密码子优化的含A27L质粒进行疫苗接种可减少痘苗病毒攻击后的病毒复制和传播。
Vaccine. 2017 Oct 20;35(44):6007-6014. doi: 10.1016/j.vaccine.2017.05.091. Epub 2017 Jun 16.
5
Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.在小鼠模型中,用改良安卡拉痘苗病毒和已获许可的天花疫苗Dryvax联合接种所赋予的增强免疫原性和保护作用。
Virology. 2005 Sep 1;339(2):164-75. doi: 10.1016/j.virol.2005.06.002.
6
Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.用安卡拉改良痘苗病毒或传统李斯特疫苗进行暴露后免疫接种,在人类天花的小鼠模型中可提供可靠的保护。
J Infect Dis. 2009 Jan 1;199(1):39-48. doi: 10.1086/595565.
7
The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection.非复制型天花候选疫苗痘苗病毒李斯特株缺陷型(dVV-L)和改良痘苗病毒安卡拉株(MVA)可引发强大的长期保护作用。
Virology. 2005 Oct 10;341(1):91-101. doi: 10.1016/j.virol.2005.06.043.
8
Heterogeneity in the A33 protein impacts the cross-protective efficacy of a candidate smallpox DNA vaccine.A33蛋白的异质性影响了一种候选天花DNA疫苗的交叉保护效力。
Virology. 2008 Jul 20;377(1):19-29. doi: 10.1016/j.virol.2008.04.003. Epub 2008 May 14.
9
Short- and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccine.非复制型天花候选疫苗在小鼠体内诱导的短期和长期免疫原性及保护作用,并与传统第一代疫苗进行比较。
Vaccine. 2008 Mar 25;26(14):1794-804. doi: 10.1016/j.vaccine.2007.12.059. Epub 2008 Feb 12.
10
Efficacy of novel plasmid DNA encoding vaccinia antigens in improving current smallpox vaccination strategy.编码痘苗抗原的新型质粒DNA在改进当前天花疫苗接种策略中的功效。
Vaccine. 2006 May 22;24(21):4461-70. doi: 10.1016/j.vaccine.2005.08.010. Epub 2005 Aug 18.

引用本文的文献

1
Comparing New-Generation Candidate Vaccines against Human Orthopoxvirus Infections.比较新一代针对人类正痘病毒感染的候选疫苗。
Acta Naturae. 2017 Apr-Jun;9(2):88-93.